The page is the record's research on the issuer — no analyst, no rating, no view.

# SynAct Pharma AB (Nasdaq Stockholm: SE0008241491) — research page

As of 2026-11-06 · se-cm-kg · record version 1

## Identity and listing

The issuer is SynAct Pharma AB, listed on Nasdaq Stockholm, with ticker SE0008241491, ISIN SE0008241491 and LEI 549300RRYIEFEQ72N546. The security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.

## The disclosure read

The record holds 49 filings across 45 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.5 days. The median latency from the latest filing to the record date is 7.0 days for the exchange, against 2 days for this issuer. The exchange median is 9.5 days for cadence and 30.0 filings for the window, across 398 issuers. The sector median is not on the record. The latest filing is an Investor News item dated 2026-11-04.

## Auditor

The auditor and its location are not on the record. Auditor changes are not on the record.

## Events and halts

The listing, delisting, name change, domicile change and segment move lines are not on the record, because the index carries no lifecycle type map for this register. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1.

## Coverage

Two research houses are named on the issuer's investor-relations page: Edison Investment Research and BioVal BioStock Analytics.

## Open research

One openly published research note is on the record: Edison Investment Research, dated 2025-10-28.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://firds.esma.europa.eu/firds/ (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.se-cm-kg.ai/events/XSTO/SE0008241491 (the disclosure lines)
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.synactpharma.com/en/investors/analysts/ (coverage)
- https://www.edisongroup.com/research/differentiated-inflammation-resolution-approach/BM-2174/ (open research)
- https://mcp.se-cm-kg.ai/record/XSTO/SE0008241491 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/se/XSTO/SE0008241491 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp